https://www.selleckchem.com/products/WP1130.html
OBJECTIVE To assess the outcomes and toxic effects of 5-day actinomycin D (Act-D) salvage therapy and to explore the predictors of Act-D resistance in patients with low-risk gestational trophoblastic neoplasia (GTN)who failed 5-day methotrexate (MTX) chemotherapy. METHODS This retrospective study analyzed patients with low-risk GTN administered Act-D salvage therapy after failing MTX chemotherapy at Women's Hospital, Zhejiang University School of Medicine between January 2000 and December 2015. The clinical parameters of these patients w
Curtir
Comentario
Compartilhar
